Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T17:06:26.016Z.
Calculation as of: 2026-10-06T17:06:26.016Z.
Quote observation: 2026-10-06T17:05:18.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 3328ed161ff00c537a80d7dceb604f662f1c22c4e65cb57a824bf36ce3bbbe60
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
Corvus Pharmaceuticals, Inc.
Market Cap
$868.65M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$863.49M
EV/EBIT Ratio
9.68x
TTM Avg
6.42x
3Y Avg
12.92x
5Y Avg
12.92x
Market Cap
$857.24M
EV/EBIT Ratio
N/A
TTM Avg
33.92x
3Y Avg
15.14x
5Y Avg
22.68x
Market Cap
$887.93M
EV/EBIT Ratio
5.93x
TTM Avg
5.93x
3Y Avg
5.93x
5Y Avg
5.93x
Market Cap
$840.18M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$839.73M
EV/EBIT Ratio
N/A
TTM Avg
76.83x
3Y Avg
76.83x
5Y Avg
76.83x
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Corvus Pharmaceuticals, Inc. (CRVS) | $868.65M | N/A | N/A | N/A | N/A |
| Rigel Pharmaceuticals, Inc. (RIGL)vs › | $863.49M | 9.68x | 6.42x | 12.92x | 12.92x |
| SI-BONE, Inc. (SIBN)vs › | $860.99M | N/A | N/A | N/A | N/A |
| SL Science Holding Ltd (SLBT)vs › | $858.07M | N/A | N/A | N/A | N/A |
| QuidelOrtho Corporation (QDEL)vs › | $857.24M | N/A | 33.92x | 15.14x | 22.68x |
| Arbutus Biopharma Corp (ABUS)vs › | $887.93M | 5.93x | 5.93x | 5.93x | 5.93x |
| SpyGlass Pharma, Inc. Common Stock (SGP)vs › | $840.18M | N/A | N/A | N/A | N/A |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $839.73M | N/A | 76.83x | 76.83x | 76.83x |
| Bioventus Inc. (BVS)vs › | $897.61M | 18.31x | 17.93x | 24.19x | 30.14x |
| Alumis Inc. (ALMS)vs › | $835.64M | N/A | N/A | N/A | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
